PHARMA BUYL-LOUISE
ActiveSummary
PHARMA BUYL-LOUISE has been active since 2021 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €152,271 and a net result of €72,981. Equity has been growing by about 21% per year since 2021. Its solvency ranks better than 55% of 5,040 sector peers (NACE 47, financial year 2025). The computed 12-month bankruptcy probability is 0.9% (low).
Overview
Official details
Source: KBO- Status
- Active since 11-03-2021 Normal situation
- Activity
- Retail sale of pharmaceutical products NACE 47730
- Establishment unit
- 2.314.897.674 1050 Elsene, since 11-03-2021
- Financial year end
- 31 December
- Peppol
- Reachable since 05-09-2025
Board and ownership
- ANTOINE JOELLEDirector · since 11-03-2021
- Holdings
- Shares in 1 company PHARMACIE LOUISE
Financial position
- Bankruptcy probabilitywithin 12 months
- 0.9%
- Gross margin
- €93,537
- ▲ 1.5%
- Turnover
- ≈ €460,000
- estimated
- Profit
- €72,981
- ▲ 2.0%
- Equity
- €152,271
- ▲ 0.6%
- Total assets
- €380,658
- ▼ 2.8%
Score breakdownraises riskFounded in 2021Sector: Retail trade (NACE 47)Liquidity: current ratio 1.19, cash €7,501lowers riskSize: total assets €380,658Show the evidence
Checked score
About 9 in 1,000 comparable companies go bankrupt within 12 months (an estimate).
Calculation
The band follows from the bankruptcy probability. 10 more points roughly halve it.
| 75-100 | Excellent | under 0.55% |
| 60-74 | Healthy | 0.55% to 1.5% |
| 45-59 | Fair | 1.5% to 4.2% |
| 25-44 | Weak | 4.2% to 15.0% |
| 0-24 | Critical | over 15.0% |
Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (NACE 47, micro). It does better than 55% of them on solvency, 38% on liquidity, 80% on profitability and 42% on growth.
The bankruptcy probability was computed on 04-11-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.
Some facts cap the score, however low the probability. With negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late, the score is Fair at most (59). With two missing filings, it is Weak at most (44). During a judicial reorganisation or at the company's end (bankruptcy, dissolution, liquidation), it is Critical at most (24).
Credit check for an amount and term of your choice
Show the recommended maximum and see how the verdict changes with amount, term and advance.
The scores and ratios are Checked's own calculations, not a credit decision.
Signals
The company filed its last 5 accounts on average 34 days before the deadline. In the sector (NACE 47), the median for financial year 2024 was on the deadline day, and 47% of those companies filed late.
Searched, nothing found (2)
Key points
- Positive: 5 profitable years in a rowprofit 2025: €72,981 5 years View
Recent changes
- · Gazette deed Incorporation
Comparable companies
These companies have the same main activity as PHARMA BUYL-LOUISE: retail sale of pharmaceutical products (NACE 47730). They are comparable in size and age: total assets between €307,000 and €469,000, founded between 2019 and 2022.
| Company | Total assets | Gross margin |
|---|---|---|
| PHARMA BUYL-LOUISE Elsene | €380,658 | €93,537 |
| PHARMACIE DU LAC Rixensart | €399,426 | €103,305 |
| VIPHARMA Saint-Ghislain | €467,095 | €86,908 |
| APOTHEEK VRIJBROEK Mechelen | €387,647 | €76,982 |
| Guerder Gentelet Robin Elsene | €307,307 | €82,652 |
| PHARMACIE DE CAMPINE Liège | €317,399 | €109,432 |
| Pharmacie Nathalie Elsen Andenne | €468,661 | €113,594 |
Key facts about PHARMA BUYL-LOUISE
- What is the company number of PHARMA BUYL-LOUISE?
- The company number of PHARMA BUYL-LOUISE is 0764.926.261. The VAT number is the same number with BE in front: BE 0764.926.261.
- Where is PHARMA BUYL-LOUISE based?
- The registered office is at Adolphe Buyllaan 1, 1050 Elsene.Company details
- What does PHARMA BUYL-LOUISE do?
- According to the KBO register, the main activity is retail sale of pharmaceutical products (NACE 47730).
- What is the legal form of PHARMA BUYL-LOUISE?
- The legal form of PHARMA BUYL-LOUISE is Private limited company (BV).
- When was PHARMA BUYL-LOUISE founded?
- PHARMA BUYL-LOUISE was founded on 11-03-2021.
- Is PHARMA BUYL-LOUISE still active?
- Yes, PHARMA BUYL-LOUISE is an active enterprise in the KBO register.
- What is the turnover of PHARMA BUYL-LOUISE?
- The turnover in financial year 2025 is ≈ €460,000. This figure is estimated from the gross margin of €93,537 and 73 comparable companies (NACE 477). It probably lies between €220,000 and €660,000.Financials
- Is PHARMA BUYL-LOUISE profitable?
- In financial year 2025, PHARMA BUYL-LOUISE made a profit of €72,981.
- Where can I find the annual accounts of PHARMA BUYL-LOUISE?
- PHARMA BUYL-LOUISE filed 5 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
- When are the next annual accounts of PHARMA BUYL-LOUISE due?
- PHARMA BUYL-LOUISE must file the annual accounts for financial year 2026 by 31-07-2027.Timeline
Next steps
See how customers, suppliers and banks see your own company and what to improve first.